MAR-PRAVASTATIN

marcan pharmaceuticals inc🇨🇦 Health Canada

Approval Id: ef54008b8bada55e
Drug Approval Canada Name: MAR-PRAVASTATIN
Product Name: MAR-PRAVASTATIN
Status: Marketed
Status Date: 2023-08-21
Original Market Date: 2018-04-05
Din: 02432064
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 24:06.08
Atc Original: C10AA03 PRAVASTATIN
Atc Name: c 10 aa 03
Aig Number: 0122563003
Company Name: marcan pharmaceuticals inc
Company Address: 2 Gurdwara Rd., Suite 112, Ottawa, Ontario, Canada, K2E 1A2

PRAVASTATIN SODIUM

40 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

ef54008b8bada55e

Type

Standard